Matches in Nanopublications for { ?s ?p "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.
- assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413790.RAjEZycT1JrAQvjCYMuId2KJPee2MYk-ddLYzE9MPCUyw130_provenance.
- NP841376.RAMg9FKAw0YoU9u0DFDZCOfzmaOGMS4zLSPgc_Pbx71qc130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841376.RAMg9FKAw0YoU9u0DFDZCOfzmaOGMS4zLSPgc_Pbx71qc130_provenance.
- NP413791.RA6ieHllWSSfk6KEVhiSYjdA8b0YCgsQY5lN8hH1OuTKE130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413791.RA6ieHllWSSfk6KEVhiSYjdA8b0YCgsQY5lN8hH1OuTKE130_provenance.
- NP413792.RA28jrvLXgq-9ux3EVKRX7Ru2GdWq6u49FiuHIl6oHmpA130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413792.RA28jrvLXgq-9ux3EVKRX7Ru2GdWq6u49FiuHIl6oHmpA130_provenance.
- NP413794.RA-DbKUT8BbY-N8eTQ45Pkq0cSGffKywknAOQuuT7Z9K4130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413794.RA-DbKUT8BbY-N8eTQ45Pkq0cSGffKywknAOQuuT7Z9K4130_provenance.